USE OF RECOMBINANT CLOSTRIDIAL NEUROTOXINS FOR THE TREATMENT OF PATIENTS HAVING CERTAIN MUSCLE-RELATED DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170189500A1
SERIAL NO

15317399

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to novel uses of recombinant clostridial neurotoxins exhibiting decreased duration of effect, in particular uses for the treatment of patients having experienced muscle-related disorders and/or injuries.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERZ PHARMA GMBH & CO KGAA60318 FRANKFURT AM MAIN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FINK, Klaus Köln, DE 17 41
GRAFE, Susanne Düsseldorf, DE 12 98
JORDAN, Deryck Frankfurt am Main, DE 1 0
ROLL, Susanna Stadecken-Elsheim, DE 4 0
SCHULTZ, Imke Rodgau, DE 5 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation